INJ
Injective Protocol
#65
交易平台
交易对
交易平台
货币
时间
货币
USD

未找到该货币

$11.91
+3.85%
最低价:$0.65567454
最高价:$52.75
INJ
排名
#65
市值
$1,185,471,284.51
完全摊薄估值
$1,191,000,000.00
24H 现货交易量
$82,547,511.29
流通供应量
99,970,935
总供应量
100,000,000
最大供给
100,000,000
项目开始时间
2020年10月19日
关于
1. Background IntroductionInjective is a decentralized finance (DeFi) protocol built on the Cosmos SDK, designed to provide a fully decentralized exchange (DEX) infrastructure. It focuses on enabling permissionless trading of various financial products, including spot, derivatives, and forex markets. The project was founded in 2018 and has gained traction for its cross-chain capabilities and developer-friendly ecosystem.2. Core Website ContentThe website showcases Injective's key offerings: a decentralized order book, cross-chain trading, and zero gas fees for users. It highlights partnerships with major blockchain projects and emphasizes its community-driven governance model. The site also features developer tools, ecosystem projects, and educational resources about decentralized finance.3. Technical FeaturesInjective utilizes Tendermint-based Proof-of-Stake consensus and offers Ethereum Virtual Machine (EVM) compatibility through its custom Injective Chain. Unique technical aspects include front-running prevention mechanisms, on-chain order book matching, and IBC protocol integration for cross-chain interoperability. The platform supports perpetual swaps, futures, and other derivative products with decentralized price feeds.4. Token EconomicsThe native INJ token serves multiple purposes: governance voting, staking for security, protocol fee discounts, and as collateral for derivatives trading. The tokenomics model includes deflationary mechanisms through weekly token burns based on exchange fees. The total supply is capped at 100 million INJ, with current circulating supply around 80 million.5. Competitor ComparisonCompared to similar projects like dYdX (order book DEX), Injective offers broader cross-chain functionality beyond Ethereum. Versus Perpetual Protocol (synthetic assets), Injective provides more traditional financial instruments. Unlike centralized exchanges like Binance, Injective maintains full decentralization while offering comparable trading features. Its closest competitor is perhaps Serum on Solana, though Injective's Cosmos-based architecture offers different interoperability advantages.6. Risks and ChallengesKey challenges include regulatory uncertainty around derivatives trading, competition from both centralized and decentralized exchanges, and the technical complexity of maintaining cross-chain functionality. The project also faces adoption barriers as it competes with established trading platforms with greater liquidity. Smart contract risks and potential vulnerabilities in its novel consensus mechanism present additional technical challenges.7. Industry FutureInjective positions itself at the intersection of several growing trends: cross-chain interoperability, institutional DeFi adoption, and the expansion of decentralized derivatives markets. The platform could benefit from increasing demand for non-custodial trading solutions and the broader adoption of Cosmos ecosystem technologies. Its success will depend on maintaining technical innovation while building sufficient liquidity across its markets.8. SummaryInjective presents an ambitious decentralized trading solution with strong technical foundations and clear product-market fit in the growing DeFi derivatives space. While facing significant competition and technical challenges, its unique combination of cross-chain capabilities, diverse financial products, and community governance model gives it distinctive advantages. The project's long-term success will hinge on its ability to attract liquidity, navigate regulatory landscapes, and continue innovating in the rapidly evolving DeFi sector. 更多>
最新快讯
2025年06月16日 星期一